It is possible that the antiviral outcome of thymalin consists in compensatory stimulation of HSC [human hematopoietic stem mobile] differentiation into CD28+T lymphocytes in the phase of immunity suppression in unfavorable program of viral an infection.”Cancer models: Ehrlich tumor models in mice allow evaluation of thymulin's results on tumor e… Read More